Antigenic peptides encoded by cancer testis antigens used in the cytokine secretion assay
| Protein . | HLA (I) restriction . | HLA frequency (%) within the population . | Peptide sequence . |
|---|---|---|---|
| MAGE-A1 | |||
| 96-104 | A3 | 23 | SLFRAVITK |
| 135-143 | A24 | 19 | NYKHCFPEI |
| 161-169 | A1 | 26 | EADPTGHSY |
| 289-298 | B7 | 17 | RVRFFFPSL |
| MAGE-A2 | |||
| 157-166 | A2 | 44 | YLQLVFGIEV |
| MAGE-A3 | |||
| 97-105 | A24 | 19 | TFPDLESEF |
| 112-120 | A2 | 44 | KVAEELVHFL |
| 168-176 | A1/B35 | 26 | EVDPIGHLY |
| 195-203 | A24 | 19 | IMPKAGLLI |
| MAGE-A1/A2/A3/A6 | |||
| 121-134 | DR13 | 19 | LLKYRAREPVTKAE |
| MAGE-A3 | |||
| 149-160 | DR4/7 | 24, 25 | VIFSKASSSLQL |
| 191-205 | DR11 | 25 | GDNQIMPKAGLLIIV |
| 243-258 | DP4/DQ-6 | 75, 63 | KKLLTQHFVQENYLEY |
| 281-295 | DR11 | 25 | TSYVKVLHHMVKISG |
| Protein . | HLA (I) restriction . | HLA frequency (%) within the population . | Peptide sequence . |
|---|---|---|---|
| MAGE-A1 | |||
| 96-104 | A3 | 23 | SLFRAVITK |
| 135-143 | A24 | 19 | NYKHCFPEI |
| 161-169 | A1 | 26 | EADPTGHSY |
| 289-298 | B7 | 17 | RVRFFFPSL |
| MAGE-A2 | |||
| 157-166 | A2 | 44 | YLQLVFGIEV |
| MAGE-A3 | |||
| 97-105 | A24 | 19 | TFPDLESEF |
| 112-120 | A2 | 44 | KVAEELVHFL |
| 168-176 | A1/B35 | 26 | EVDPIGHLY |
| 195-203 | A24 | 19 | IMPKAGLLI |
| MAGE-A1/A2/A3/A6 | |||
| 121-134 | DR13 | 19 | LLKYRAREPVTKAE |
| MAGE-A3 | |||
| 149-160 | DR4/7 | 24, 25 | VIFSKASSSLQL |
| 191-205 | DR11 | 25 | GDNQIMPKAGLLIIV |
| 243-258 | DP4/DQ-6 | 75, 63 | KKLLTQHFVQENYLEY |
| 281-295 | DR11 | 25 | TSYVKVLHHMVKISG |